click below
click below
Normal Size Small Size show me how
NICOLE/PHAT132
STUDY GUIDE
Question | Answer |
---|---|
PHARMACODYNAMICS | STUDY OF HOW DRUGS INTERACT IN THE HUMAN BODY. |
PHARMACOKENETICS | STUDY OF THE ABSORPTION DISTRIBUTION, BIOTRANSTORMATION EXCRETION OF DRUGS. |
PHARMACOTHERAPEUTICS | STUDY OF HOW DRUGS ARE USED IN THE TREATMENT OF DISEASE IN THE HUMAN BODY. |
PHARMACY | STUDY PF PREPARING AND DISPENSING MEDICATIONS |
POSOLOGY | THE STUDY OF THE EXACT AMOUNT OF A DRUG THAT IS NEEDED IN ORDER TO PRODUCE A THERAPEUTIC EFFECT. |
TOXICOLOGY | STUDY OF POISONS,THEIR DETECTION, THEIR EFFECTS AND ESTABLISHING ANTIDOTS AND METHODS OF TREATMENT FOR CONDITIONS THEY PRODUCE. |
PHARMOCOGNOSY | STUDY OF DRUGS DERIVED FROM HERBAL AND OTHER NATURAL SOURCES |
THE TERMS MEDICATION REFER TO | DRUGS MIXED IN A FORMULATION TO FOLLOW APPROPRIATE ADMINISTRATION OF THE ACTIVE DRUG. |
PHARMACOLOGY | DEALS WITH ALL OF THE DRUGS IN SOCIETY TODAY. THOSE THAT ARE LEGAL,ILLEGAL,RX,OTC |
WHAT IS THE MOST COMMONLY SAMPLED BODILY FLUID USED TO CHARACTERIZE THE PHAMACOLOGIC ACTION OF DRUGS. | BLOOD |
WHAT ARE THE FACTORS THAT INFLUENCE THE ONSET DURATION AND INTENSITY OF DRUG EFFECTS | ABSORPTION,METABOLISM,REABSORPTION,EXCREATION,SITE OF ACTION AND OBSERVED RESPONSE |
WHAT ARE FACTORS THAT AFFECT DRUG ACTIONS | AGE SEX BODY WEIGHT DIURIAL BODY RYTHMS DISEASES ALLERGIES PSYCHOLOGICAL FACTORS DRUG HALF LIFE TOLERANCE DRUG TOXICITY AND DRUG INTERACTIONS. |
DRUG HALF LIFE | THIS IS THE MAJOR DETERMINING FACTOR IN HOW OFTEN A DRUG MAYBE GIVEN |
AGE | AGE AFFECT METABOLIC RATE IMPORTANCE RULE OF THUMB WHEN DEALING W/PEDIATRIC AND GERIATRIC PTS START SLOW GO SLOW |
SEX GENDER | DRUGS ADMINISTERED IM ARE ABSORBED FASTER BY MEN THAN WOMEN. THEY REMAIN IN WOMANS TISSUES B/C WOMEN HAVE A HIGHER BODY FAT CONTENT. |
BODY WEIGHT | SAME DOSE OF MEDICATION CANHAVE VARIED AFFECTS ON PATIENTS WHOSE BODY WEIGHTS DIFFER SOME MEDICATION DOSES MUST BE ADJUSTED BODY WEIGHT AND BODY SURFACE AREA,ESPECIALLY IN CHILDREN. |
DIURIAL BODY RHYTHMS | CIRCULATION RYTHMS SLEEP PATTERNS HAVE A TENDENCY TO INTENSIFY A PATIENT RESPONSE TO A MEDICATION |
DISEASE | ESPECIALLY OF THE LIVER AND KIDNEY THE LIVER IS THE MAJOR SITE FOR DETOXIFICATION AND THE KIDNEYS ARE THE MAJOR SITE OF ELIMINATION OF CHEMICAL SUBSTANCE |
WHAT ARE THE 2 TYPES OF ANTIBIOTICS | BACTERIACIDAL-KILLS BACTERIA AND BACTERIOSTATIC-INHIBITS THE GROWTH OF BACTERIA |
adverse affects | harmful effects |
AGONIST | DRUG THAT BINDS TO A RECEPTOR AND PRODUCES AN APPROPRIATE PHYSIOLOGIC RESPONSE THAT IS SIMILAR TO WHAT AN ENDOGENOUS SUBSTANCE WOULD DO. |
ANAPHYLACTIC SHOCK | A SUDDEN AND SEVERE ALLERGIC REACTION THAT MAY BE LIFE THREATINING |
ANTAGONIST | AN AGENT THAT ACTS IN PHYSIOLOGIC OPPOSITION IN PHARMACOLOGY IT IS AN AGENT THAT PREVENTS AN AGONIST FROM BINDING TO A RECEPTOR,THERE BY BLOCKING ITS EFFECTS. |
BIOAVAILIBILITY | THE DEGREE AND RATE AT WHICH A DRUG IS ABSORBED INTO A LIVING SYSTEM OR IS MADE AVAILABLE AT THE SITE OF PHYSIOLOGIC ACTION |
BIOTRANSFORMATION | THE PROCESS OF CONVERSION OF DRUGS WITHIN THE BODY |
ADVERSE DRUG REACTION | ANY UNEXPECTED OBVIOUS CHANGE IN THE PATIENTS CONDITION THAT THE PHYSICIAN SUSPECTS MAY BE DUE TO A DRUG |
DOSE EFFECT RELATIONSHIP | THE RELATIONSHIP BETWEEN THE DOSE OF A DRUG THAT PRODUCES HARMFUL EFFECTS AND THE SEVERITY OF THE EFFECTS ON THE PATIENT |
DRUG INDICATION | THE EXACT REASON FOR THE USE OF THE DRUG |
HALF LIFE | THE TIME TAKEN FOR THE BLOOD OR PLASMA CONCENTRATION OF THE DRUG TO DECREASE FROM FULL TO HALF |
OVERDOSE | A TOXIC DOSE OF A DRUG OR OTHER SUBSTANCE |
SIDE EFFECTS | RESULT OF A DRUG OR OTHER THERAPY IN ADDITION TO OR IN EXTENSION OF THE DESIRED THERAPEUTIC EFFECTS WHICH ARE USUALLY BUT NOT ALWAYS UNDESIRABLE |
TOLERANCE | THE BODYS SLOW ADAPTION TO A DRUG HIGHER DOSES ARE REQUIRED TO ACHIEVE THE SAME AFFECT REDUCED RESPONSIVENESS TO A DRUG |
TOXICITY | THE STATE OF BEING N OXIOUS REFERS TO DRUGS ABILITY TO POISON THE BODY |